Cibc World Markets Corp Gilead Sciences, Inc. Transaction History

Cibc World Markets Corp

$15 Billion
Q2 2024

A detailed history of Cibc World Markets Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 250,728 shares of GILD stock, worth $21 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

250,728

Previous 207,001 21.12%

Holding current value

$21 Million

Previous $15.2 Million 13.45%

% of portfolio

0.11%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $2.76 Million - $3.19 Million	43,727 Added 21.12%	250,728 $17.2 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $17.6 Million - $21.5 Million	-246,246 Reduced 54.33%	207,001 $15.2 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $4.31 Million - $4.89 Million	-58,865 Reduced 11.49%	453,247 $36.7 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $19.3 Million - $21.1 Million	261,479 Added 104.33%	512,112 $38.4 Million
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $10.4 Million - $11.8 Million	136,212 Added 119.04%	250,633 $19.3 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $18.1 Million - $20.6 Million	-233,947 Reduced 67.16%	114,421 $9.49 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $2.84 Million - $4.08 Million	-45,650 Reduced 11.59%	348,368 $29.9 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $14.1 Million - $16.1 Million	236,543 Added 150.21%	394,018 $24.3 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $7.9 Million - $8.9 Million	-136,874 Reduced 46.5%	157,475 $9.73 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $2.92 Million - $3.66 Million	-50,463 Reduced 14.63%	294,349 $17.5 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $660,348 - $749,507	10,178 Added 3.04%	344,812 $25 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $15.8 Million - $17.1 Million	233,964 Added 232.41%	334,634 $23.4 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $4.27 Million - $4.66 Million	-67,210 Reduced 40.03%	100,670 $6.93 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $96.3 Million - $110 Million	-1,604,361 Reduced 90.53%	167,880 $10.9 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $80.5 Million - $91.8 Million	1,421,508 Added 405.3%	1,772,241 $103 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $9.1 Million - $11.4 Million	146,459 Added 71.7%	350,733 $22.2 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $3.48 Million - $4.04 Million	-48,082 Reduced 19.05%	204,274 $15.7 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $7.33 Million - $9.39 Million	-117,089 Reduced 31.69%	252,356 $18.9 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $53.1 Million - $58.4 Million	-861,244 Reduced 69.98%	369,445 $24 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $55.7 Million - $61.5 Million	891,043 Added 262.34%	1,230,689 $78 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $842,607 - $944,886	13,619 Added 4.18%	339,646 $22.9 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $49.2 Million - $55.1 Million	-786,398 Reduced 70.69%	326,027 $21.2 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $5.42 Million - $7.07 Million	89,516 Added 8.75%	1,112,425 $69.6 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $5.21 Million - $5.77 Million	73,082 Added 7.69%	1,022,909 $79 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $5 Million - $5.83 Million	77,001 Added 8.82%	949,827 $67.3 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $25.1 Million - $30.6 Million	-344,969 Reduced 28.33%	872,826 $65.8 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $12.9 Million - $15.2 Million	181,918 Added 17.56%	1,217,795 $87.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $74.7 Million - $88.5 Million	1,035,877	1,035,877 $83.9 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Gilead Sciences, Inc. Transaction History